The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of pancreatic cancer: hope,” Jarvis writes.

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the existing CA 19-9 test, it was able to diagnose early-stage pancreatic cancer with 85% accuracy.

After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I committed myself to being there for my cousin.

Pancreatic cancer kills three in four people within the first year ... Trump told reporters that Ukrainian President Volodymyr Zelenskyy wants to come to Washington on Feb 28 to sign a 'very big deal' which comes after the two leaders exchanged hostile ...